Filing Details
- Accession Number:
- 0000899243-23-001838
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-17 16:05:20
- Reporting Period:
- 2023-01-12
- Accepted Time:
- 2023-01-17 16:05:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1274792 | Merrimack Pharmaceuticals Inc | MACK | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1548707 | Newtyn Partners, Lp | 60 East 42Nd Street, 9Th Floor New York NY 10165 | No | No | No | Yes | |
1548709 | Newtyn Te Partners, Lp | 60 East 42Nd Street, 9Th Floor New York NY 10165 | No | No | No | Yes | |
1569241 | Newtyn Management, Llc | 60 East 42Nd Street, 9Th Floor New York NY 10165 | No | No | No | Yes | |
1788608 | G. Noah Levy | 60 East 42Nd Street, 9Th Floor New York NY 10165 | Yes | No | No | Yes | |
1789643 | Newtyn Capital Partners, Lp | 60 East 42Nd Street, 9Th Floor New York NY 10165 | No | No | No | Yes | |
1789647 | Ledo Capital, Llc | 60 East 42Nd Street, 9Th Floor New York NY 10165 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-01-12 | 100,000 | $11.90 | 1,119,586 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
Footnotes
- The shares are directly held by NP. The general partner of the Funds is NCP. The general partner of NCP is Ledo. The investment manager to the Funds is Newtyn Management. The managing member of Newtyn Management and Ledo and the portfolio manager to the Funds is Mr. Levy. Each of Newtyn Management, Ledo, NCP and Mr. Levy disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.